Gregg D. Simonson

1.4k total citations
32 papers, 556 citations indexed

About

Gregg D. Simonson is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Gregg D. Simonson has authored 32 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Gregg D. Simonson's work include Diabetes Management and Research (13 papers), Diabetes Management and Education (10 papers) and Diabetes Treatment and Management (6 papers). Gregg D. Simonson is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes Management and Education (10 papers) and Diabetes Treatment and Management (6 papers). Gregg D. Simonson collaborates with scholars based in United States and Spain. Gregg D. Simonson's co-authors include V Iwanij, Kevin Roberg, Richard M. Bergenstal, Yue Huang, Thomas W. Martens, David M. Kendall, Michael J. MacDonald, Mary L. Johnson, Anders L. Carlson and Amy Criego and has published in prestigious journals such as Diabetes Care, Diabetes and Journal of Cell Science.

In The Last Decade

Gregg D. Simonson

31 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregg D. Simonson United States 12 204 151 150 115 94 32 556
Hiroaki Akai Japan 16 160 0.8× 328 2.2× 73 0.5× 127 1.1× 57 0.6× 32 754
Adán Valladares‐Salgado Mexico 16 163 0.8× 222 1.5× 38 0.3× 89 0.8× 164 1.7× 50 717
K. Paletas Greece 5 334 1.6× 156 1.0× 84 0.6× 105 0.9× 24 0.3× 7 536
Esteban Jorge‐Galarza Mexico 15 209 1.0× 80 0.5× 40 0.3× 126 1.1× 41 0.4× 46 648
Helle C. Thiesson Denmark 15 125 0.6× 228 1.5× 67 0.4× 94 0.8× 25 0.3× 47 700
Muradiye Nacak Türkiye 13 61 0.3× 130 0.9× 103 0.7× 34 0.3× 37 0.4× 29 598
Özen Öz Gül Türkiye 12 219 1.1× 102 0.7× 37 0.2× 112 1.0× 30 0.3× 78 451
Andrea Repaci Italy 18 556 2.7× 181 1.2× 101 0.7× 204 1.8× 103 1.1× 51 1.1k
Marı́a Teresa Tusié-Luna Mexico 16 302 1.5× 598 4.0× 55 0.4× 226 2.0× 306 3.3× 34 1.1k
Ümit Karayalçın Türkiye 15 299 1.5× 98 0.6× 32 0.2× 136 1.2× 38 0.4× 33 646

Countries citing papers authored by Gregg D. Simonson

Since Specialization
Citations

This map shows the geographic impact of Gregg D. Simonson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregg D. Simonson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregg D. Simonson more than expected).

Fields of papers citing papers by Gregg D. Simonson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregg D. Simonson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregg D. Simonson. The network helps show where Gregg D. Simonson may publish in the future.

Co-authorship network of co-authors of Gregg D. Simonson

This figure shows the co-authorship network connecting the top 25 collaborators of Gregg D. Simonson. A scholar is included among the top collaborators of Gregg D. Simonson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregg D. Simonson. Gregg D. Simonson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simonson, Gregg D., et al.. (2024). Unleashing the Potential of Blood Glucose Monitoring Data With the Ambulatory Glucose Profile Report. Clinical Diabetes. 42(4). 550–560. 2 indexed citations
2.
Martens, Thomas W., Gregg D. Simonson, & Richard M. Bergenstal. (2024). Using continuous glucose monitoring data in daily clinical practice. Cleveland Clinic Journal of Medicine. 91(10). 611–620. 4 indexed citations
3.
Rodríguez, Luis A., Romain Neugebauer, Tainayah Thomas, et al.. (2024). Race and ethnicity and pharmacy dispensing of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. The Lancet Regional Health - Americas. 34. 100759–100759. 18 indexed citations
4.
Martens, Thomas W., Gregg D. Simonson, Anders L. Carlson, & Richard M. Bergenstal. (2024). Primary Care and Diabetes Technologies and Treatments. Diabetes Technology & Therapeutics. 26(S1). S–153. 3 indexed citations
5.
Simonson, Gregg D., Thomas W. Martens, Anders L. Carlson, & Richard M. Bergenstal. (2023). Primary Care and Diabetes Technologies and Treatments. Diabetes Technology & Therapeutics. 25(S1). S–161. 1 indexed citations
6.
Martens, Thomas W., Gregg D. Simonson, Anders L. Carlson, & Richard M. Bergenstal. (2021). Primary Care and Diabetes Technologies and Treatments. Diabetes Technology & Therapeutics. 23(S2). S–143. 2 indexed citations
7.
Simonson, Gregg D., Robert Cuddihy, Diane Reader, & Richard M. Bergenstal. (2011). International Diabetes Center Treatment of Type 2 Diabetes Glucose Algorithm. Diabetes Management. 1(2). 175–189. 14 indexed citations
8.
Mazze, Roger S., Ellie S. Strock, Gregg D. Simonson, & Richard M. Bergenstal. (2006). Staged Diabetes Management. 10 indexed citations
9.
Simonson, Gregg D. & David M. Kendall. (2006). Different actions of peroxisome proliferator-activated receptors: molecular mechanisms and clinical importance. Current Opinion in Endocrinology & Diabetes. 13(2). 162–170. 5 indexed citations
10.
Simonson, Gregg D. & David M. Kendall. (2005). Diagnosis of insulin resistance and associated syndromes: the spectrum from the metabolic syndrome to type 2 diabetes mellitus. Coronary Artery Disease. 16(8). 465–472. 26 indexed citations
11.
Mazze, Roger S., et al.. (2004). Undetected, uncontrolled blood pressure in type 2 diabetes: self‐monitored blood pressure profiles. Blood Pressure. 13(6). 335–342. 10 indexed citations
12.
Mazze, Roger S., Ellie S. Strock, Gregg D. Simonson, & Richard M. Bergenstal. (2004). Staged Diabetes Management: A Systematic Approach. 20 indexed citations
13.
Simonson, Gregg D., Rachel L. Robinson, David M. Kendall, et al.. (2003). Characterizing blood pressure control in individuals with Type 2 diabetes: the relationship between clinic and self‐monitored blood pressure. Diabetic Medicine. 20(9). 752–757. 12 indexed citations
14.
Simonson, Gregg D., et al.. (2000). Prevention of diabetes related amputations in an American Indian community using staged diabetes management. Diabetes Research and Clinical Practice. 50. 408–408. 2 indexed citations
15.
Welty‐Wolf, Karen E., Gregg D. Simonson, Yuh-Chin T. Huang, et al.. (1996). ULTRASTRUCTURAL CHANGES IN SKELETAL MUSCLE MITOCHONDRIA IN GRAM-NEGATIVE SEPSIS. Shock. 5(5). 378–384. 37 indexed citations
16.
Simonson, Gregg D., et al.. (1996). Synthesis and Processing of Genetically Modified Human Proinsulin by Rat Myoblast Primary Cultures. Human Gene Therapy. 7(1). 71–78. 49 indexed citations
17.
Simonson, Gregg D. & V Iwanij. (1995). Genomic organization and promoter sequence of a gene encoding a rat liver-specific type-1 transport protein. Gene. 154(2). 243–247. 11 indexed citations
18.
MacDonald, Michael J., S.M. Moran, & Gregg D. Simonson. (1995). The Amino Acid Sequence of the Pancreatic Islet Mitochondrial Glycerol Phosphate Dehydrogenase Is Not Unique and the Enzyme Is Not Thyroid or Glucose Responsive. Archives of Biochemistry and Biophysics. 319(1). 305–308. 6 indexed citations
19.
Lehn, Donald A., Laura E. Brown, Gregg D. Simonson, Susan M. Moran, & Michael J. MacDonald. (1994). The sequence of a human mitochondrial glycerol-3-phosphate dehydrogenase-encoding cDNA. Gene. 150(2). 417–418. 18 indexed citations
20.
Simonson, Gregg D., et al.. (1994). Molecular cloning and characterization of a novel liver-specific transport protein. Journal of Cell Science. 107(4). 1065–1072. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroaki Akai Breakdown of academic impact, for papers by Adán Valladares‐Salgado Breakdown of academic impact, for papers by K. Paletas Breakdown of academic impact, for papers by Esteban Jorge‐Galarza Breakdown of academic impact, for papers by Helle C. Thiesson Breakdown of academic impact, for papers by Muradiye Nacak Breakdown of academic impact, for papers by Özen Öz Gül Breakdown of academic impact, for papers by Andrea Repaci Breakdown of academic impact, for papers by Marı́a Teresa Tusié-Luna Breakdown of academic impact, for papers by Ümit Karayalçın
Rankless by CCL
2026